Advair is NYSE: GSK 's largest selling drug. It sells around $4.6b annually worldwide. The drug is currently facing generic competition in Europe, however the impact not been very painful until ...

GlaxoSmithKline gains 2.7 percent after Novartis hands back U.S. rights to a drug widely thought to be a generic copy of its blockbuster Advair, reducing the threat of cheap copies of the lung ...

1. Wixela Inhub is Mylan’s generic version of Advair, an asthma treatment made by GlaxoSmithKline. 2. Tosymra is a sumatriptan nasal spray used to treat migraines in adults. 3. Imbruvica in ...

There was a 3 percent increase in U.S. list prices in September for some GSK products, including Advair and heart drug Lovaza, which will give a small boost, although it will only affect one month ...

GSK expects that it respiratory sales in 2020 will be at atleast at the same levels as in 2015. Advair generic competition will knock off almost 50% of GSK's respiratory business by 2020. The much ...

Advair Diskus would now cost Schmidtknecht $539.19 out of pocket, and the pharmacy allegedly told him there were no cheaper alternatives or generic medications available to him.

Trunk, though, said Wednesday that the $5 generic prescription Cole filled was for his rescue inhaler, not the Advair Diskus inhaler that he took daily.